肠道过境时间可能在结肠曲症中加快,独立于粘膜血清素信号传递
Piotr Nehring1, Miłosz Jastrzębski1, Ilona Joniec-Maciejak2
1Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
Journal of clinical medicine
|December 30, 2025
概括
与健康个体相比,患有结肠偏症的患者可能会经历更快的肠道过渡时间. 这种加速过渡时间似乎与结肠中关键生物胺的代谢无关.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠健康 结肠直肠健康
- 身体生理学 身体生理学
背景情况:
- 结肠分泌症在老年人中很普遍,影响肠道习惯和生活质量.
- 肠内静脉,对于肠道过渡至关重要,受到生物胺的影响.
研究的目的:
- 在患有结肠分泌症的患者中调查肠道过渡时间.
- 为了探索结肠生物胺水平和肠道过渡时间在分泌瘤之间的关系.
主要方法:
- 一项对23名参与者进行的前性比较研究 (14名患有分,9名对照).
- 结肠镜用活检和SITZMARKS®标记测试检测肠道过境时间.
- 评估的结肠粘膜生物胺:MHPG,NA,DA,HVA,5-HT,5-HIAA. 这些生物氨基酸包括:
主要成果:
- 患有分泌突症的患者表现出更快排便的趋势 (48小时内标记物保留率较低,p<0.027).
- 两组之间没有发现结肠生物胺度 (5-HT,5-HIAA,MHPG,NA,DA,HVA) 的显著差异.
结论:
- 肠道过渡时间可能会在结肠异症患者中加速.
- 转瘤中加速过渡可能独立于结肠生物胺代谢.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
851
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
851
Drugs for Treatment of Diarrhea-Predominant IBS
593
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
593
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
349
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
349
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
506
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
506
Drugs for Treatment of Constipation-Predominant IBS
670
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
670
Irritable Bowel Syndrome I: Introduction
885
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
885


